| A randomized trial of closed-loop control in children with type 1 diabetes MD Breton, LG Kanapka, RW Beck, L Ekhlaspour, GP Forlenza, E Cengiz, ... New England Journal of Medicine 383 (9), 836-845, 2020 | 384 | 2020 |
| Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial LM Laffel, LG Kanapka, RW Beck, K Bergamo, MA Clements, A Criego, ... JAMA 323 (23), 2388-2396, 2020 | 379* | 2020 |
| Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial RE Pratley, LG Kanapka, MR Rickels, A Ahmann, G Aleppo, R Beck, ... JAMA 323 (23), 2397-2406, 2020 | 320* | 2020 |
| Racial-ethnic inequity in young adults with type 1 diabetes S Agarwal, LG Kanapka, JK Raymond, A Walker, A Gerard-Gonzalez, ... The Journal of Clinical Endocrinology & Metabolism 105 (8), e2960-e2969, 2020 | 164 | 2020 |
| Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial J Ware, CK Boughton, JM Allen, ME Wilinska, M Tauschmann, L Denvir, ... The Lancet Digital Health 4 (4), e245-e255, 2022 | 73 | 2022 |
| A meta-analysis of randomized trial outcomes for the t: slim X2 insulin pump with control-IQ technology in youth and adults from age 2 to 72 RW Beck, LG Kanapka, MD Breton, SA Brown, RP Wadwa, ... Diabetes Technology & Therapeutics 25 (5), 329-342, 2023 | 65 | 2023 |
| Predictors of time-in-range (70–180 mg/dL) achieved using a closed-loop control system MJ Schoelwer, LG Kanapka, RP Wadwa, MD Breton, KJ Ruedy, ... Diabetes Technology & Therapeutics 23 (7), 475-481, 2021 | 59 | 2021 |
| Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes KM Miller, LG Kanapka, MR Rickels, AJ Ahmann, G Aleppo, L Ang, ... Diabetes technology & therapeutics 24 (6), 424-434, 2022 | 54 | 2022 |
| Health-related quality of life and treatment satisfaction in parents and children with type 1 diabetes using closed-loop control EC Cobry, LG Kanapka, E Cengiz, L Carria, L Ekhlaspour, ... Diabetes technology & therapeutics 23 (6), 401-409, 2021 | 54 | 2021 |
| Extended use of the control-IQ closed-loop control system in children with type 1 diabetes LG Kanapka, RP Wadwa, MD Breton, KJ Ruedy, L Ekhlaspour, ... Diabetes Care 44 (2), 473-478, 2021 | 43 | 2021 |
| Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM study AL Carlson, LG Kanapka, KM Miller, AJ Ahmann, NS Chaytor, S Fox, ... Journal of Diabetes Science and Technology 15 (3), 582-592, 2021 | 39 | 2021 |
| Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents KK Hood, N Garcia‐Willingham, S Hanes, ML Tanenbaum, J Ware, ... Diabetes, Obesity and Metabolism 24 (12), 2309-2318, 2022 | 28 | 2022 |
| Insulin pump infusion set failures associated with prolonged hyperglycemia: frequency and relationship to age and type of infusion set during 22,741 infusion set wears LG Kanapka, JW Lum, RW Beck Diabetes technology & therapeutics 24 (6), 396-402, 2022 | 26 | 2022 |
| Time in range is associated with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study VN Shah, LG Kanapka, HK Akturk, S Polsky, GP Forlenza, C Kollman, ... Diabetes Technology & Therapeutics 26 (4), 246-251, 2024 | 22 | 2024 |
| Autism spectrum disorder in children with Type 1 diabetes KE Bethin, LG Kanapka, LM Laffel, S Majidi, NS Chaytor, S MacLeish, ... Diabetic Medicine 36 (10), 1282-1286, 2019 | 22 | 2019 |
| Continuous glucose monitoring profiles in healthy, nondiabetic young children SN DuBose, LG Kanapka, B Bradfield, M Sooy, RW Beck, AK Steck Journal of the Endocrine Society 6 (6), bvac060, 2022 | 20 | 2022 |
| The insulin-only bionic pancreas pivotal trial extension study: a multi-center single-arm evaluation of the insulin-only configuration of the bionic pancreas in adults and … Bionic Pancreas Research Group, J Lynch, LG Kanapka, SJ Russell, ... Diabetes technology & therapeutics 24 (10), 726-736, 2022 | 19 | 2022 |
| Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study LA DiMeglio, LG Kanapka, DJ DeSalvo, BJ Anderson, KR Harrington, ... Diabetic Medicine 37 (8), 1308-1315, 2020 | 17 | 2020 |
| Characteristics of adult‐compared to childhood‐onset type 1 diabetes A Casu, LG Kanapka, NC Foster, IB Hirsch, LM Laffel, VN Shah, ... Diabetic Medicine 37 (12), 2109-2115, 2020 | 14 | 2020 |
| A hierarchical modelling approach to assess multi pollutant effects in time-series studies M Blangiardo, M Pirani, L Kanapka, A Hansell, G Fuller PLoS One 14 (3), e0212565, 2019 | 14 | 2019 |
